Perspective Therapeutics (CATX) EBITDA Margin (QoQ) (2010 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 68,441.00
Sep 30, 2023 20,404.00
Jun 30, 2023 -11,688.00
Sep 30, 2022 -16,101.00
Jun 30, 2022 -3,679.00
Mar 31, 2022 1,078.00
Dec 31, 2021 3,063.00
Sep 30, 2021 -13,836.00
Jun 30, 2021 7,913.00
Mar 31, 2021 755.00
Dec 31, 2020 -706.00
Sep 30, 2020 2,222.00
Jun 30, 2020 -3,314.00
Mar 31, 2020 2,191.00
Dec 31, 2019 -482.00
Sep 30, 2019 2,335.00
Jun 30, 2019 99.00
Mar 31, 2019 1,461.00
Dec 31, 2018 2,213.00
Sep 30, 2018 5,066.00
Jun 30, 2018 -6,272.00
Mar 31, 2018 1,045.00
Dec 31, 2017 3,259.00
Sep 30, 2017 790.00
Jun 30, 2017 -2,771.00
Mar 31, 2017 3,553.00
Dec 31, 2016 183.00
Sep 30, 2016 -3,373.00
Jun 30, 2016 -120.00
Mar 31, 2016 782.00
Dec 31, 2015 -3,207.00
Sep 30, 2015 -413.00
Jun 30, 2015 837.00
Mar 31, 2015 500.00
Dec 31, 2014 1,567.00
Sep 30, 2014 2,763.00
Jun 30, 2014 -5,187.00
Mar 31, 2014 903.00
Dec 31, 2013 2,136.00
Sep 30, 2013 -3,539.00
Jun 30, 2013 -1,634.00
Mar 31, 2013 4,686.00
Dec 31, 2012 -641.00
Sep 30, 2012 -3,459.00
Jun 30, 2012 -1,381.00
Mar 31, 2012 656.00
Dec 31, 2011 2,638.00
Sep 30, 2011 -2,984.00
Jun 30, 2011 -1,185.00
Mar 31, 2011 182.00
Dec 31, 2010 1,446.00